Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for prevention of acute kidney injury after on-pump cardiac surgery
ChiCTR1900026747Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ulinastatin in acute kidney failure (AKF) (2 arms), sponsored by Renji Hospital. Primary endpoints: Serum creatinine and Urine output. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR1900026747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026747.